New York, NY -- (SBWIRE) -- 12/10/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hudson Technologies, Inc (NASDAQ:HDSN), Goodrich Petroleum Corporation (NYSE:GDP), Rite Aid Corporation (NYSE:RAD), Brainstorm Cell Therapeutics Inc (OTCBB:BCLI)
Hudson Technologies, Inc (NASDAQ:HDSN) showed a volume of 2.47 million shares by the end of last trade whereas the average volume of the stock remained 126,715.00 shares. The stock opened the session at $2.55 but then moved to $3.59. At that price, the stock showed a positive performance of 40.78%. Hudson Technologies, Inc. is a refrigerant services company providing solutions to recurring problems within the refrigeration industry. The Company's products and services are primarily used in commercial air conditioning, industrial processing and refrigeration systems, and include refrigerant sales, refrigerant management services consisting primarily of reclamation of refrigerants and RefrigerantSide Services performed at a customer's site, consisting of system decontamination to remove moisture,
Will HDSN Continue To Move Higher? Find Out Here
Goodrich Petroleum Corporation (NYSE:GDP) opened the session at $18.00 and closed the session at $17.08. The stock showed a negative performance of -4.69% in previous trading session. Traded with volume of 2.51 million shares in the prior session and the average volume of the stock remained 1.80 million shares. Goodrich Petroleum Corporation is an independent oil and natural gas company engaged in exploration, development and production of oil and natural gas on properties primarily in Northwest Louisiana, East Texas and South Texas. It includes the Haynesville Shale and Cotton Valley Taylor Sand in Northwest Louisiana and East Texas, the Eagle Ford Shale and Buda Lime formations in South Texas and the Tuscaloosa Marine Shale in Southeast Louisiana and Southwest Mississippi.
Has GDP Found The Bottom And Ready To Gain Momentum? Find Out Here
Rite Aid Corporation (NYSE:RAD) opened the session at $5.81 and closed the session at $5.69. The stock showed a negative performance of -1.04% in previous trading session. Traded with volume of 25.49 million shares in the prior session and the average volume of the stock remained 25.16million shares. The beta of the stock remained 2.42. Rite Aid Corporation is a retail drugstore chain in the United States. As of March 3, 2013, it operated 4,623 stores in 31 states across the country and in the District of Columbia. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2013 (fiscal 2013), prescription drug sales accounted for 67.6% of its total sales. It carries a range of front end products, which accounted for 32.4% of its total sales in fiscal 2013.
Why Should Investors Buy RAD After the Recent Fall? Just Go Here and Find Out
Brainstorm Cell Therapeutics Inc (OTCBB:BCLI) the stock decreased -14.83% and finished the session at $0.150. Traded with volume of 3.29 million shares in the prior session and the average volume of the stock remained 201,158.00 shares. The beta of the stock remained -0.16. BrainStorm Cell Therapeutics Inc. is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD) and Spinal Cord Injury. These diseases have limited treatment options and as such represent unmet medical needs.
Will BCLI Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)